Navigation Links
Concord Medical Reports Third Quarter 2012 Financial Results
Date:11/20/2012

illion), of which RMB456.6 million ($72.7 million) was utilized.

During the third quarter of 2012, the Company handled 10,632 patient treatment cases and 73,922 patient diagnostic cases, representing 18.9% and 47.9% increases from the third quarter of 2011, respectively.

Hospital businessNet revenues from the hospital business were RMB91.7 million ($14.6 million) for the third quarter of 2012, which consisted of:

  • outpatient revenues of RMB18.3 million ($2.9 million), representing 20% of the net revenues from the hospital business;
  • inpatient revenues of RMB30.7 million ($4.9 million), representing 33% of the net revenues from the hospital business; and
  • pharmacy revenues of 42.8 million ($6.8 million), representing 47% of the net revenues from the hospital business.
  • Cost of service for the hospital business for the third quarter of 2012 was RMB77.1 million ($12.3 million).

    Gross profit margin of the hospital business was 15.9% for the third quarter of 2012.

    As of September 30, 2012, Chang'an Hospital had accounts receivable of RMB37.2 million ($5.9 million), representing days sales outstanding of 34 days. The accounts receivable was mainly from medical revenues covered by various government-sponsored insurance programs. Chang'an Hospital settles the balance with the local social insurance bureau on a periodic basis. The Company considers the collection risk to be low.

    Based on the preliminary purchasing price allocation (the "PPA") results, we have identified intangible assets as well as prepaid land lease payments valued at RMB184.8 million ($29.4 million). The intangible assets include information system, healthcare qualification and oncology operation licenses. The resulting amortization expense in the third quarter of RMB4.3 million ($0.7 million) was included in Chang'an Hospital's cost of revenue and operating expenses. The PPA results are subject to changes.

    Ch
    '/>"/>

    SOURCE Concord Medical Services Holdings Limited
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
    2. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
    3. Concord Medical Responds to Unusual Market Activity in its Stock
    4. Concord Medical Reports Second Quarter 2012 Financial Results
    5. Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
    6. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
    7. Concord Medicals Changan Hospital and Fox Chase Cancer Center Sign Strategic Alliance Agreement
    8. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
    9. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
    10. Cutting-Edge German Medical Innovations Put Patients First
    11. Medical Device Market Updates: IVD and Ophthalmic Devices Dominate Chinas $30.5 bn Medical Device Market; Invisible Hearing Aids Set to Make Big Noise
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
    (Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
    (Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
    Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
    ... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
    ... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
    Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
    (Date:9/1/2015)... ... ... Royal River Natural Foods, a locally-owned independent natural health store in Freeport, ... and found that, among those who had a stroke, people who used multivitamins survived ... the September 2015 issue of “Natural Insights for Well Being,” which Royal River Natural ...
    (Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, ... has joined its medical management team as an Associate Medical Director. , ... and types in the U.S. and abroad. , Dr. Nelson has a ...
    (Date:9/1/2015)... ... , ... Two of Washington D.C.’s most respected chefs are using their global ... Recently named “the next big thing” in the culinary world by Elle Spain, award-winning ... behind food and reclaiming culinary traditions on the brink of extinction. According to Amy ...
    (Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... SC&H Group, ... (IPA), which includes being named a “Best of the Best” firm in the U.S., ... has named the “Best of the Best” in the U.S., selected exclusively on performance ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... is now available. With the Connectivity Kit, EasySampler data is automatically ... lab reactor control experiment, on a touchscreen platform. , EasySampler fully automates ...
    Breaking Medicine News(10 mins):Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3
    ... Feb. 25 Dialysis Corporation,of America (Nasdaq: DCAI ... Carolina, has been certified and in now open and ... the state, began,construction last year, as previously announced., ... in the,Southeastern United States continues to expand, we are ...
    ... Engine Implementations Begin for HEAL 1 ... ... subsidiary of Quest Diagnostics Incorporated (NYSE:,DGX), announced today that it has ... health information exchanges (HIE),qualified for HEAL NY (Healthcare Efficiency and Affordability ...
    ... 2008, WASHINGTON, Feb. 25 In response ... payment bundling report,released earlier this week, Kidney Care ... professionals, care providers and manufacturers,working together to improve ... kidney failure -- applauds CMS for issuing its ...
    ... for a Healthier You, ORLANDO, Fla., Feb. 25 ... in 2008 but still find yourself having a soda,and cold ... implement your,New Year,s resolutions and Sun Shower(TM) has a variety ... 2008., "It,s not too late to have a healthy ...
    ... Maryland at College Park have discovered that Normal Human ... zinc level, at the high end of plasma zinc ... up-regulation of growth arrest and DNA damage-induced gene (Gadd45) ... cycle progression. The research, published in the March 08 ...
    ... 25 AT&T Inc. (NYSE: T ),today ... a preferred insurer dedicated to developing and delivering,insurance ... health,care providers., Under terms of the agreement, ... LAMMICO,s four domestic locations; three in Louisiana and,an ...
    Cached Medicine News:Health News:Dialysis Corporation of America Announces its Newest Center Opening in South Carolina 2Health News:MedPlus Technology Driving Three New York Health Information Exchanges 2Health News:MedPlus Technology Driving Three New York Health Information Exchanges 3Health News:MedPlus Technology Driving Three New York Health Information Exchanges 4Health News:MedPlus Technology Driving Three New York Health Information Exchanges 5Health News:MedPlus Technology Driving Three New York Health Information Exchanges 6Health News:Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report 2Health News:Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report 3Health News:Still Time to Make a 'Healthy Diet' New Year's Resolution 2Health News:High zinc status in lung cells slows growth and induces DNA damage-induced gene expression 2Health News:High zinc status in lung cells slows growth and induces DNA damage-induced gene expression 3Health News:AT&T Enhances Performance for LAMMICO With Upgraded Network Services 2Health News:AT&T Enhances Performance for LAMMICO With Upgraded Network Services 3
    ... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
    ... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
    Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
    Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
    Medicine Products: